Susquehanna International Group
BNTC icon

Susquehanna International Group’s Benitec Biopharma BNTC Stock Holding History

Susquehanna International Group’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$127K Buy
+11,908
New +$138K ﹤0.01% 12171
2025
Q3 		– Sell
-17,728
Closed -$207K – 12431
2025
Q2 		$207K Sell
17,728
-208,368
-92% -$2.92M ﹤0.01% 11138
2025
Q1 		$2.94M Buy
226,096
+201,324
+813% +$2.44M ﹤0.01% 4693
2024
Q4 		$313K Buy
+24,772
New +$268K ﹤0.01% 9751
2022
Q3 		– Sell
-3,170
Closed -$62K – 13178
2022
Q2 		$62K Buy
+3,170
New +$73.7K ﹤0.01% 11841
2019
Q3 		– Sell
-291
Closed -$55K – 10159
2019
Q2 		$55K Buy
291
+12
+4% +$4.87K ﹤0.01% 9821
2019
Q1 		$135K Buy
279
+53
+23% +$22.8K ﹤0.01% 8120
2018
Q4 		$87K Buy
226
+91
+67% +$50.3K ﹤0.01% 8279
2018
Q3 		$84K Sell
135
-135
-50% -$92.2K ﹤0.01% 8665
2018
Q2 		$137K Buy
270
+50
+23% +$33.8K ﹤0.01% 8901
2018
Q1 		$166K Buy
220
+143
+186% +$120K ﹤0.01% 8457
2017
Q4 		$58K Buy
+77
New +$53.8K ﹤0.01% 8869

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Susquehanna International Group's BNTC Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Benitec Biopharma (BNTC) in Q1 2026: 11,908 shares worth $127K. The stake represents ﹤0.01% of the portfolio and ranks #12171 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in BNTC as recently as Q2 2025.

Susquehanna International Group first reported a position in BNTC in Q4 2017 and has held it in 12 quarters since. The position peaked at $2.94M in Q1 2025. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Susquehanna International Group held 11,908 shares of Benitec Biopharma worth $127K as of Q1 2026.
  • Benitec Biopharma was a new Susquehanna International Group position in Q1 2026.
  • Benitec Biopharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12171 holding.
  • Susquehanna International Group first reported a position in Benitec Biopharma in Q4 2017 and has held it in 12 quarters since.
  • Susquehanna International Group's Benitec Biopharma position peaked at $2.94M in Q1 2025.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.